Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Intellipharmaceutics Company Profile (NASDAQ:IPCI)

Consensus Ratings for Intellipharmaceutics (NASDAQ:IPCI) (?)
Ratings Breakdown: 3 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.25)
Consensus Price Target: $5.80 (110.14% upside)

Analysts' Ratings History for Intellipharmaceutics (NASDAQ:IPCI)
Show:
DateFirmActionRatingPrice TargetDetailsShare
7/9/2014Maxim GroupDowngradeBuy -> Hold$7.00 -> $3.00ViewTweet This Rating  Share This Rating on StockTwits
5/1/2014Maxim GroupLower Price TargetBuy$9.00 -> $7.00ViewTweet This Rating  Share This Rating on StockTwits
3/12/2014MackieInitiated CoverageSpeculative BuyC$11.00ViewTweet This Rating  Share This Rating on StockTwits
11/19/2013Brean CapitalReiterated RatingBuy$7.00ViewTweet This Rating  Share This Rating on StockTwits
11/19/2013ZacksReiterated RatingHold$2.20ViewTweet This Rating  Share This Rating on StockTwits
11/19/2013Maxim GroupBoost Price TargetBuy$7.00 -> $9.00ViewTweet This Rating  Share This Rating on StockTwits
9/10/2013ZacksDowngradeOutperform -> Neutral$2.20ViewTweet This Rating  Share This Rating on StockTwits
7/16/2013ZacksUpgradeNeutral -> Outperform$1.80ViewTweet This Rating  Share This Rating on StockTwits
1/31/2013Maxim GroupInitiated CoverageBuy$7.00ViewTweet This Rating  Share This Rating on StockTwits
9/11/2012Brean CapitalInitiated CoverageBuy$7.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/22/2012 forward)